Efficacy of the Cardiac Rehabilitation Program in Patients with End-Stage Heart Failure, Heart Transplant Patients, and Left Ventricular Assist Device Recipients

被引:61
|
作者
Karapolat, H. [1 ]
Engin, C. [2 ]
Eroglu, M. [1 ]
Yagdi, T. [2 ]
Zoghi, M. [2 ]
Nalbantgil, S. [2 ]
Durmaz, B. [1 ]
Kirazli, Y. [1 ]
Ozbaran, M. [2 ]
机构
[1] Ege Univ, Phys Med & Rehabil Dept, TR-35100 Izmir, Turkey
[2] Ege Univ, Dept Cardiac Surg, TR-35100 Izmir, Turkey
关键词
QUALITY-OF-LIFE; FUNCTIONAL-CAPACITY; DEPRESSIVE SYMPTOMS; EXERCISE CAPACITY; TIME-COURSE; METAANALYSIS; TRIAL;
D O I
10.1016/j.transproceed.2013.06.009
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Objective. The objective of this study was to assess the effects of cardiac rehabilitation on the functional capacity, pulmonary functions, quality of life, and psychological state of patients who had heart failure (HF), heart transplantation (HTx), or a left ventricular assist device (LVAD). Methods. An 8-week exercise program was undertaken by 46 patients diagnosed with end-stage heart failure, 40 of whom had a heart transplantation and 11 were implanted with an LVAD. The patients' functionality was assessed with a maximal oxygen consumption test (pVO(2)), their psychological state with the Beck Depression Inventory (BDI) and State-Trait Anxiety Inventory (STAI), their quality of life (QOL) with the Short Form 36 (SF 36), and their pulmonary condition with pulmonary function tests (PFTs). Results. A significant improvement was observed in all forced vital capacity (%), forced expiratory volume in 1 second (%), pVO(2), BDI, and most of the subscores of the SF 36 scores at the end of the exercise, compared with the pre-exercise period (P <.05). The intergroup evaluations showed no significant differences among the 3 groups in terms of all assessed changes (F>.05). Conclusion. An 8-week supervised exercise program was observed to improve functional capacity, PFT, QOL, and depression among patients who had HF, HTx, or LVAD. Supervised exercise should be recommended for every patient included in a heart transplant program.
引用
收藏
页码:3381 / 3385
页数:5
相关论文
共 50 条
  • [21] Left ventricular assist device for end-stage heart failure: results of the first LVAD destination program in the Netherlands
    Haeck, M. L. A.
    Beeres, S. L. M. A.
    Hoke, U.
    Palmen, M.
    Couperus, L. E.
    Delgado, V.
    Logeman, E. A.
    Maas, J. J.
    Klautz, R. J. M.
    Schalij, M. J.
    Verwey, H. F.
    NETHERLANDS HEART JOURNAL, 2015, 23 (02) : 102 - 108
  • [22] Left ventricular assist device for end-stage heart failure: results of the first LVAD destination program in the Netherlands
    M. L. A. Haeck
    S. L. M. A. Beeres
    U. Höke
    M. Palmen
    L. E. Couperus
    V. Delgado
    E. A. Logeman
    J. J. Maas
    R. J. M. Klautz
    M. J. Schalij
    H. F. Verwey
    Netherlands Heart Journal, 2015, 23 : 102 - 108
  • [23] Clinical outcomes of patients with end-stage heart failure treated with left ventricular assist devices
    Di Carlo, Marta
    Marchetti, Maria Francesca
    Tramontin, Corrado
    Corda, Marco
    Porcu, Maurizio
    Agus, Elena
    Boi, Giacomo
    Cirio, Emiliano
    Meloni, Luigi
    Montisci, Roberta
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (SUPPL G)
  • [24] Clinical outcomes of patients with end-stage heart failure treated with left ventricular assist devices
    Di Carlo, Marta
    Marchetti, Maria Francesca
    Tramontin, Corrado
    Corda, Marco
    Porcu, Maurizio
    Agus, Elena
    Boi, Giacomo
    Cirio, Emiliano
    Meloni, Luigi
    Montisci, Roberta
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2021, 23 (0G)
  • [25] Sex Differences in Patients Receiving Left Ventricular Assist Devices for End-Stage Heart Failure
    Gruen, Jadry
    Caraballo, Cesar
    Miller, P. Elliott
    McCullough, Megan
    Mezzacappa, Catherine
    Ravindra, Neal
    Mullan, Clancy W.
    Reinhardt, Samuel W.
    Mori, Makoto
    Velazquez, Eric
    Geirsson, Arnar
    Ahmad, Tariq
    Desai, Nihar R.
    JACC-HEART FAILURE, 2020, 8 (09) : 770 - 779
  • [26] Does left ventricular assist device implantation modulate the cardiac cell apoptosis in end-stage heart failure?
    Prescimone, T.
    Caruso, R.
    Campolo, J.
    Caselli, C.
    Cabiati, M.
    Boroni, C.
    Del Ry, S.
    Parodi, O.
    Giannessi, D.
    EUROPEAN HEART JOURNAL, 2011, 32 : 81 - 81
  • [27] Left ventricular assist device implantation On track to becoming the new gold standard for patients with end-stage heart failure
    Krabatsch, Thomas
    Potapov, E.
    Knosalla, C.
    Falk, Volkmar
    EUROPEAN HEART JOURNAL, 2016, 37 (23) : 1785 - 1786
  • [28] Normalisation of Haemodynamics in Patients with End-stage Heart Failure with Continuous-flow Left Ventricular Assist Device Therapy
    Gupta, Sunil
    Woldendorp, Kei
    Muthiah, Kavitha
    Robson, Desiree
    Prichard, Roslyn
    Macdonald, Peter S.
    Keogh, Anne M.
    Kotlyar, Eugene
    Jabbour, Andrew
    Dhital, Kumud
    Granger, Emily
    Spratt, Phillip
    Jansz, Paul
    Hayward, Christopher S.
    HEART LUNG AND CIRCULATION, 2014, 23 (10): : 963 - 969
  • [29] Histopathological Analysis as Predictive Markers of Recovery from End-Stage Heart Failure in Patients with Left Ventricular Assist Device
    Takahashi, Ayako
    Ueda, Hatsue I.
    Satake, Masamichi
    Matsuyama, Taka-Aki
    Ikeda, Yoshihiko
    Yanase, Masanobu
    Kato, Tomoko S.
    Kitakaze, Masafumi
    Nakatani, Takeshi
    Tomoike, Hitonobu
    CIRCULATION, 2008, 118 (18) : S800 - S800
  • [30] Sympathetic vasoconstrictor activity before and after left ventricular assist device implantation in patients with end-stage heart failure
    Heusser, Karsten
    Wittkoepper, Judith
    Bara, Christoph
    Haverich, Axel
    Diedrich, Andre
    Levine, Benjamin D.
    Schmitto, Jan D.
    Jordan, Jens
    Tank, Jens
    EUROPEAN JOURNAL OF HEART FAILURE, 2021, 23 (11) : 1955 - 1959